BRS2-2-6 - Glutathione Synthesis
(Assembling glutathione from glutamate, cysteine and glycine)
1. Mission & Overview + Dietary Levers
Mission
Build glutathione from sulfur amino acids so cellular antioxidant defence stays connected to one-carbon metabolism.
Intervention Dominance: Diet-Dominant
-
Cysteine
-
Methionine
-
Glutamate
-
Glycine
-
N-acetylcysteine
-
Magnesium
- ATP
No mapping established.
Overview
Cells assemble glutathione, the main intracellular thiol, in two ATP-dependent steps. [1] Glutamate–cysteine ligase joins glutamate and cysteine, then glutathione synthetase adds glycine. [1] [2] A sulfur-amino-acid-free diet slowed whole-blood synthesis in healthy young men. [3] Combined precursor supplements raised erythrocyte synthesis in older adults. [4] These tracer studies measured synthesis in blood cells, not in the brain. [3] [4]
- Benefits: Cells draw on this thiol to limit oxidative stress. In older adults, higher blood-cell synthesis after precursor supplements came with lower plasma oxidative-stress markers. [4] That thiol is how sulfur amino acids from one-carbon metabolism stay connected to cellular antioxidant defence.
- Implementation Notes: Cysteine, methionine, glutamate, glycine, and N-acetylcysteine are the provision routes. [3] [4] A methionine-adequate cysteine-free diet did not lower erythrocyte synthesis in young men, so these results do not set a routine dose. [5]
- Biological Relevance: Clearing peroxides and recycling oxidised glutathione are separate from this assembly. [8] [9]
2. Primary Biological Effects
↑ glutathione formation from glutamate, cysteine and glycine
↑ γ-glutamylcysteine as the intermediate of the first step
→ later peroxide removal and glutathione recycling remain outside this reaction
3. Intervention Levers
No preparation method, supplement schedule, or fasting pattern has been shown to change these two assembly reactions.
No sleep, activity, or stress-recovery behaviour has been shown to change these assembly reactions. Cells make the ATP the enzymes use, but that has not been tied to a lifestyle lever for glutathione synthesis.
4. Mechanistic Basis
Summary
Glutathione formation is the point at which glutamate, cysteine and glycine become the cell's main low-molecular-weight thiol. The defining events are the two ATP-dependent assembly steps. Making the cysteine, and later using or recycling the glutathione, are separate processes.
(Two ATP-dependent assembly steps)
Glutathione (GSH; γ-glutamylcysteinylglycine) is built in two steps that each use ATP (the cell's energy-carrying molecule). Glutamate–cysteine ligase joins the side-chain carboxyl of glutamate to cysteine, forming γ-glutamylcysteine (a two-amino-acid intermediate) [1]. Glutathione synthetase then adds glycine, and the human enzyme binds one magnesium ion per subunit [2]. The reviewed constants for the purified first enzyme give cysteine a lower Km (0.1 mM) than glutamate (1.8 mM) [1]. That biochemical preference is not the same thing as a universal dietary cysteine shortage.
(When human blood-cell synthesis changes)
In seven healthy young men, removing methionine and cysteine from an otherwise adequate amino-acid formula for 10 days lowered whole-blood fractional synthesis from 0.65 ± 0.13 to 0.49 ± 0.13 per day and lowered absolute synthesis by about 23%, while glutathione concentration stayed near 1.2 mM. Glycine in that formula was increased, not reduced [3]. In older adults, erythrocyte synthesis was lower than in younger adults and rose after two weeks of a cysteine precursor, supplied as N-acetylcysteine, together with glycine [4]. When methionine was held at 14 mg/kg/day, cysteine intakes from zero to 40 mg/kg/day did not change erythrocyte synthesis in four young men [5].
(What is outside the assembly reactions)
Selenium is part of glutathione peroxidase: human glutathione peroxidase uses an active-site selenocysteine and glutathione to reduce peroxides [8]. Riboflavin is relevant because glutathione reductase binds FAD, a riboflavin-derived cofactor, while it reduces oxidised glutathione back to the reduced form [9]. A dietary review groups these nutrients with glutathione support [6]. They act after glutathione has been made.
(Boundaries of the mechanism)
This reaction is glutathione assembly from glutamate, cysteine and glycine. Conversion of homocysteine to cysteine belongs to BRS2-FM2-PM5 — Transsulfuration Pathway. Remethylation of homocysteine belongs to BRS2-FM1-PM1 and BRS2-FM1-PM2. Using glutathione to limit lipid peroxidation belongs to BRS3-FM2-PM5 — Lipid Peroxidation Control.
(Integration within BRS2)
Within BRS2(FM2) — Transsulfuration & Redox Coupling, transsulfuration can supply cysteine and this reaction consumes it. Inadequacy of the shared methionine–cysteine pool can slow synthesis: whole-blood synthesis fell when both amino acids were removed [3]. That does not make selenium, riboflavin, or a clinical treatment part of the assembly step.
4.1 Scientific Findings (3)
Summary
Human tracer studies show context-dependent substrate responsiveness. Removing methionine and cysteine together reduced whole-blood glutathione synthesis, whereas removing cysteine with methionine kept adequate did not reduce erythrocyte synthesis in young men. [3] [5] In older adults with lower baseline synthesis, combined N-acetylcysteine and glycine supplementation raised erythrocyte synthesis. [4] These contrasts support provision under defined conditions, not universal dietary cysteine limitation; blood-cell measurements do not establish neuronal synthesis or clinical benefit.
Glutamate-cysteine ligase joins glutamate and cysteine using ATP. Glutathione synthetase then adds glycine, again using ATP, and binds magnesium. Selenium-dependent peroxidase activity and riboflavin-derived FAD in glutathione reductase are not part of these assembly reactions.
What this means
Glutamate, cysteine, glycine and ATP are the assembly substrates. Magnesium participates in the second enzyme. ATP and magnesium are intracellular biochemical requirements, not dietary levers. Selenium and riboflavin support later use and recycling of glutathione.
Evidence confidence: Not yet scored
Finding ID: PM6-F1
Finding Statement: Glutathione synthesis requires ATP-dependent formation of γ-glutamylcysteine from glutamate and cysteine, followed by ATP-dependent addition of glycine, and does not use selenium or riboflavin as synthesis substrates.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Reviewed catalytic annotation of purified human glutamate-cysteine ligase records ATP-dependent ligation of L-glutamate and L-cysteine as the first step. Human glutathione synthetase structural work records ATP-dependent addition of glycine and one bound magnesium ion per subunit as the second step. Together they define the assembly boundary. Human glutathione peroxidase uses an active-site selenocysteine to reduce peroxides with glutathione already formed, and glutathione reductase binds FAD while reducing glutathione disulfide. Those enzymes consume or restore glutathione; they do not assemble it.
Synthesis Limitations: The enzyme evidence is purified protein and structure, not intact human flux. A lower cysteine Km on the first enzyme does not prove that ordinary diets are cysteine-limited. Magnesium binding does not show that magnesium intake changes synthesis. The dietary review that groups selenium and riboflavin with glutathione support does not move those cofactors into the assembly reactions.
Evidence Considered:
- Study
- Expression and purification of human gamma-glutamylcysteine synthetase, with catalytic constants recorded in the reviewed human GCLC entry that cites this paper.
- Population
- Purified human enzyme; no human participants.
- Result
- The reaction consumes L-glutamate, L-cysteine and ATP to form γ-glutamylcysteine, ADP and phosphate. The cited annotation reports Km values of 0.1 mM for L-cysteine, 1.8 mM for L-glutamate and 0.4 mM for ATP.
- Effect / Magnitude
- Purified-enzyme Km values only; no human synthesis-rate effect.
- Evidence Summary
- Direct human-enzyme evidence for the first ATP-dependent assembly step and its amino-acid and ATP substrates.
- Limitations
- In-vitro constants do not establish in-vivo limitation, dietary responsiveness, tissue differences or clinical effects.
- Evidence Source
- Bounded external search
- Reference
- [1]
- Study
- Crystal structure of human glutathione synthetase at 2.10 Å in complex with ADP and glutathione, with catalytic and cofactor annotation.
- Population
- Crystallised human glutathione synthetase; no human participants.
- Result
- The structure and catalytic annotation place glycine and ATP in the second assembly step and record one Mg2+ ion bound per subunit.
- Effect / Magnitude
- 2.10 Å structure; no physiological effect size.
- Evidence Summary
- Direct structural evidence for the second ATP-dependent step and its magnesium ion.
- Limitations
- A product-bound structure establishes catalytic participants, not dietary dose response or in-vivo flux.
- Evidence Source
- Bounded external search
- Reference
- [2]
Connected / Supportive Evidence:
- Minich et al. (2019) [6] — MechanisticWhy relevant: Reviews dietary nutrients discussed for glutathione support, including sulfur amino acids, selenium and riboflavin.Why excluded from the primary synthesis: It is a narrative review and does not itself measure the ligase reactions, ATP use, or separation of assembly from peroxidase and reductase cofactors.
- Mullenbach et al. (1987) [8] — Cellular / MolecularWhy relevant: Shows that human glutathione peroxidase encodes an active-site selenocysteine, so selenium belongs to peroxide removal that uses glutathione.Why excluded from the primary synthesis: Peroxidase activity consumes glutathione. It is not a substrate or cofactor of either assembly enzyme.
- Karplus and Schulz (1989) [9] — Cellular / MolecularWhy relevant: Glutathione reductase structures show bound FAD, the riboflavin-derived cofactor, at the enzyme that reduces glutathione disulfide.Why excluded from the primary synthesis: Disulfide reduction is recycling of glutathione already made. FAD is not a substrate of glutamate-cysteine ligase or glutathione synthetase.
Informs: Recovery Capacity; Stress Resilience
Removing both methionine and cysteine slowed whole-blood glutathione synthesis in healthy young men. Combined cysteine-precursor and glycine supplementation raised erythrocyte synthesis in older adults. A methionine-adequate diet without cysteine did not lower erythrocyte synthesis in young men.
What this means
Substrate supply can change blood-cell synthesis in these specific conditions. That does not mean every ordinary diet is cysteine-limited, and the older-adult result is a supplemental precursor plus glycine, not a food prescription.
Evidence confidence: Not yet scored
Finding ID: PM6-F2
Finding Statement: Human blood-cell glutathione synthesis can slow when dietary methionine and cysteine are both removed and can rise in older adults after combined cysteine and glycine precursor supplementation, whereas a methionine-adequate cysteine-free diet did not limit erythrocyte synthesis in young men.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Three human tracer studies set the ceiling. In seven healthy young men, a 10-day amino-acid diet with methionine and cysteine removed lowered whole-blood fractional synthesis from 0.65 ± 0.13 to 0.49 ± 0.13 per day and lowered absolute synthesis by about 23%, while concentration stayed near 1.2 mM and glycine intake was not reduced. In eight older adults compared with eight younger adults, erythrocyte glutathione synthesis and concentration were lower, and two weeks of cysteine plus glycine precursor supplementation raised fractional synthesis by 78.8% and absolute synthesis by 230.9%. The cysteine source in that protocol is N-acetylcysteine, given with glycine. In four young men, cysteine intakes from zero to 40 mg/kg/day did not change erythrocyte synthesis when methionine was held at 14 mg/kg/day. Synthesis is therefore substrate-responsive under defined restrictions, not universally limited by dietary cysteine.
Synthesis Limitations: All three studies measured blood-cell, not neuronal, synthesis. The sulfur-amino-acid-free diet was an experimental amino-acid formula in seven young men for 10 days. The older-adult increase required combined supplementation and was not an isolated N-acetylcysteine or glycine test, not an ADHD trial, and not ordinary food. The cysteine-free arm used only four young men and two days of adaptation. Concentration did not track synthesis rate in the sulfur-amino-acid-free study.
Evidence Considered:
- Study
- Randomised crossover of two 10-day L-amino-acid diets, adequate versus methionine and cysteine both set to zero, with a primed intravenous L-[1-13C]cysteine infusion on day 10.
- Population
- Seven healthy men, age 24 ± 6 years.
- Result
- Fractional synthesis fell from 0.65 ± 0.13 to 0.49 ± 0.13 per day (P < 0.01). Absolute synthesis fell from 747 ± 216 to 578.6 ± 135 µmol/L/day (P < 0.05), about 23%. Whole-blood glutathione stayed about 1.2 mM (1,142 ± 243 versus 1,216 ± 162 µM). Glycine in the formula rose from 39.6 to 75.1 mg/kg/day so nitrogen stayed constant; glutamic acid was unchanged.
- Effect / Magnitude
- About a 23% lower absolute synthesis rate after 10 days without methionine and cysteine; concentration unchanged.
- Evidence Summary
- Direct human evidence that removing the shared sulfur-amino-acid supply slows whole-blood glutathione synthesis.
- Limitations
- Experimental formula, young men, short duration, whole blood rather than brain, and no clinical outcome. Glycine was increased, so the slowdown is not a glycine deficit.
- Evidence Source
- Bounded external search
- Reference
- [3]
- Study
- Stable-isotope erythrocyte glutathione kinetics before and after precursor supplementation. Cysteine was supplied as N-acetylcysteine together with glycine.
- Population
- Eight older adults restudied after supplementation, compared with eight younger adults.
- Result
- Before supplementation, older adults had lower erythrocyte glycine, cysteine, glutathione concentration, fractional synthesis (45.80 ± 5.69 versus 83.14 ± 6.43 %/day) and absolute synthesis (0.55 ± 0.12 versus 1.73 ± 0.16 mmol/L red cells per day). After two weeks, glutathione concentration was 94.6% higher, fractional synthesis 78.8% higher and absolute synthesis 230.9% higher, and plasma oxidative-stress markers were lower.
- Effect / Magnitude
- Combined precursor supplementation in older adults: fractional synthesis +78.8% and absolute synthesis +230.9% from the deficient baseline.
- Evidence Summary
- Human evidence that combined supplemental cysteine precursor and glycine can raise erythrocyte glutathione synthesis when it is low in older adults.
- Limitations
- Small older-adult sample, erythrocyte pool, combined supplements, not ordinary food, not neuronal synthesis, and not an ADHD or recovery trial.
- Evidence Source
- Inherited repository evidence
- Reference
- [4]
- Study
- Five graded cysteine intakes (0, 10, 20, 30 and 40 mg/kg/day) in random order with methionine fixed at 14 mg/kg/day and protein at 1 g/kg/day. Erythrocyte glutathione synthesis was measured after two days at each intake.
- Population
- Four healthy young adult men.
- Result
- Fractional and absolute erythrocyte glutathione synthesis and glutathione concentration did not change as cysteine intake increased. Urinary sulfate excretion rose with cysteine intake (r = 0.92).
- Effect / Magnitude
- No change in erythrocyte glutathione synthesis across the cysteine range tested.
- Evidence Summary
- Human evidence that dietary cysteine is not independently limiting for erythrocyte glutathione synthesis when methionine intake meets the protein requirement.
- Limitations
- Preliminary sample of four men, two-day adaptation, erythrocyte endpoint, and no neuronal or clinical outcome.
- Evidence Source
- Bounded external search
- Reference
- [5]
Evidence Dependency:
- Sekhar et al. (2011) is also used in PM6-F3 and PM6-F4 for the phenome boundary, and in PM6-IC1 for the measurement boundary. Those uses are not independent replications of the synthesis-rate result.
Informs: Recovery Capacity; Stress Resilience
Oral glutamine raised plasma glutamine/glutamate but did not raise whole-blood glutathione.
What this means
Whole-blood glutathione fell; concentrations are not synthesis rates. This does not erase glutamine metabolism, but does not support a universal glutamine-to-GSH enhancement claim.
Evidence confidence: Not yet scored
Finding ID: PM6-F5
Finding Statement: Oral glutamine raised plasma glutamine/glutamate but did not raise whole-blood glutathione.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Oral glutamine raised plasma glutamine/glutamate but did not raise whole-blood glutathione.
Synthesis Limitations: Whole-blood glutathione fell; concentrations are not synthesis rates. This does not erase glutamine metabolism, but does not support a universal glutamine-to-GSH enhancement claim.
Evidence Considered:
- Study
- 0.3 g/kg/day oral glutamine for ten days.
- Population
- Healthy volunteers studied before/after supplementation under a standardised diet.
- Result
- Oral glutamine raised plasma glutamine/glutamate but did not raise whole-blood glutathione.
- Effect / Magnitude
- Only the specified source-level endpoint is assessed; no pooled effect or food-dose estimate is inferred.
- Evidence Summary
- Plasma amino-acid and whole-blood glutathione concentrations.
- Limitations
- Whole-blood glutathione fell; concentrations are not synthesis rates. This does not erase glutamine metabolism, but does not support a universal glutamine-to-GSH enhancement claim.
- Evidence Source
- Bounded external search
- Reference
- [10]
Evidence Dependency:
- The source-specific observations support different links; food composition, biochemical identity, intervention exposure and clinical outcomes are not interchangeable. Reuse across PMs is not independent replication.
5. BRS Pathways and Connections
5.1 BRS Pathways
BRS2-FM2-PM5 — Transsulfuration Pathway ↓ BRS2-FM2-PM6 — Glutathione Synthesis
5.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS3-FM2-PM5 — Lipid Peroxidation Control — Glutathione made by these assembly steps can later be consumed when peroxides are reduced. That peroxide removal, glutathione recycling, and selenium-dependent peroxidase activity are downstream of assembly.
5.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS2-FM2-PM5 — Transsulfuration Pathway — Converts homocysteine into cysteine that the first assembly step can use. This is upstream sulfur-amino-acid supply, not the ATP-dependent reactions that form glutathione.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: Glutathione assembly supplies a thiol used in cellular redox buffering, which is relevant to recovery only as downstream biology. The human synthesis measurements are erythrocyte kinetics after combined precursor supplementation in older adults, not a recovery-outcome trial Sekhar et al. (2011) [4]. A sulfur-amino-acid-free diet slowed whole-blood synthesis while concentration was maintained Lyons et al. (2000) [3]. Higher homocysteine in boys with ADHD does not measure glutathione synthesis or recovery Lukovac et al. (2024) [7].
Supporting evidence
Glutathione assembly is biologically relevant to redox buffering, but the assessed studies do not show that changing synthesis improves Recovery Capacity.
What this means
Older-adult erythrocyte synthesis and a paediatric homocysteine difference must not be read as recovery treatment evidence.
Evidence confidence: Not yet scored
Finding ID: PM6-F3
Finding Statement: The assessed human evidence does not demonstrate that glutathione synthesis capacity changes Recovery Capacity as a functional or clinical outcome.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The older-adult trial changed erythrocyte glutathione synthesis and plasma oxidative-stress markers after combined precursor supplementation. It did not measure recovery capacity. The paediatric ADHD study measured homocysteine and vitamin B12, not glutathione synthesis and not recovery. The relationship remains a mechanistic possibility with a direct-evidence gap.
Synthesis Limitations: This is a gap in the assessed evidence, not proof that no relationship exists. Oxidative-stress markers are not a recovery phenome.
Evidence Considered:
- Study
- Erythrocyte glutathione kinetics and plasma oxidative-stress markers.
- Population
- Eight older adults and eight younger adults.
- Result
- Synthesis and glutathione concentration rose in the older group. Recovery capacity was not measured.
- Effect / Magnitude
- No recovery-outcome effect size exists in the study.
- Evidence Summary
- Supports a synthesis change, not a recovery-capacity benefit.
- Limitations
- Wrong endpoint for this phenome relationship.
- Evidence Source
- Inherited repository evidence
- Reference
- [4]
- Study
- Cross-sectional serum biomarker comparison in boys with and without ADHD.
- Population
- 133 boys aged 6.5–12.5 years.
- Result
- Homocysteine and vitamin B12 differed by ADHD status. Glutathione and recovery were not measured.
- Effect / Magnitude
- No glutathione or recovery effect.
- Evidence Summary
- Does not test this phenome relationship.
- Limitations
- Cross-sectional biomarker study in boys.
- Evidence Source
- Inherited repository evidence
- Reference
- [7]
Evidence Dependency:
- Sekhar et al. (2011) is primary synthesis evidence in PM6-F2. Its use here is only to show that the trial did not measure Recovery Capacity.
Informs: Recovery Capacity
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Rationale: The same thiol pool is a plausible contributor to stress buffering, but no assessed study tested a stress-resilience outcome Lyons et al. (2000) [3]; Sekhar et al. (2011) [4]. The paediatric ADHD biomarker study measured homocysteine and vitamin B12, not glutathione synthesis or stress resilience Lukovac et al. (2024) [7].
Supporting evidence
Substrate-responsive glutathione synthesis is relevant to redox buffering, but none of the assessed studies tested Stress Resilience.
What this means
Do not convert blood-cell synthesis changes or an ADHD homocysteine difference into a stress-resilience treatment claim.
Evidence confidence: Not yet scored
Finding ID: PM6-F4
Finding Statement: The assessed human evidence does not demonstrate that glutathione synthesis capacity changes Stress Resilience.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Sulfur-amino-acid removal and older-adult precursor supplementation changed blood-cell glutathione synthesis. Neither study measured stress resilience. The paediatric ADHD biomarker study did not measure glutathione or stress resilience. The phenome link stays mechanistic and untested.
Synthesis Limitations: Absence of a direct test is not evidence against a biological contribution. It does block treatment and dietary-advice claims.
Evidence Considered:
- Study
- Erythrocyte glutathione kinetics and plasma oxidative-stress markers.
- Population
- Eight older adults and eight younger adults.
- Result
- Erythrocyte synthesis changed. Stress resilience was not measured.
- Effect / Magnitude
- No stress-resilience effect size.
- Evidence Summary
- Synthesis evidence without a stress-resilience outcome.
- Limitations
- Endpoint mismatch for this phenome.
- Evidence Source
- Inherited repository evidence
- Reference
- [4]
- Study
- Cross-sectional serum biomarkers in boys with and without ADHD.
- Population
- 133 boys aged 6.5–12.5 years.
- Result
- Homocysteine and vitamin B12 differed. Stress resilience and glutathione were not endpoints.
- Effect / Magnitude
- No stress-resilience or glutathione effect.
- Evidence Summary
- Does not test the phenome relationship.
- Limitations
- Cross-sectional paediatric biomarker study.
- Evidence Source
- Inherited repository evidence
- Reference
- [7]
Evidence Dependency:
- Sekhar et al. (2011) is primary synthesis evidence in PM6-F2 and is reused here only for the missing stress-resilience endpoint. Lukovac et al. (2024) is also primary evidence in PM6-F3 and PM6-IC1.
Informs: Stress Resilience
Stage 2A/2B dietary-target assessment — 23 October 2026
ENRICHED. GCL/GSS construction of glutathione from its constituent amino acids.
Add the retrieved oral-glutamine null/decrease finding and provisional glycine composition sources for existing glycine. Do not admit glutamine-to-GSH enhancement: plasma amino acids rose while whole-blood GSH fell; synthesis flux was not measured. Existing cysteine, glycine, glutamate, NAC and methionine decisions remain.
New implementation: 0 dietary-input admissions (0 completed Unset candidates), 0 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.
Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.
8. References
- [1] Misra and Griffith (1998) — Human glutamate-cysteine ligase reaction
- [2] Polekhina et al. (1999) — Human glutathione synthetase and magnesium
- [3] Lyons et al. (2000) — Sulfur-amino-acid-free diet and glutathione synthesis
- [4] Sekhar et al. (2011) — Deficient glutathione synthesis in aging
- [5] Courtney-Martin et al. (2008) — Methionine-adequate cysteine-free diet
- [6] Minich et al. (2019) — A Review of Dietary (Phyto)Nutrients for Glutathione Support
- [7] Lukovac et al. (2024) — Serum Biomarker Analysis in Pediatric ADHD
- [8] Mullenbach et al. (1987) — Selenocysteine in human glutathione peroxidase
- [9] Karplus and Schulz (1989) — Glutathione reductase FAD and substrate binding
- [10] Valencia et al. (2002) — Impact of oral L-glutamine on glutathione, glutamine, and glutamate blood levels in volunteers.
No validated structured conversion route is currently projected for this PM. This does not remove or reclassify its existing dietary inputs.
Mapping state: admitted-food-coverage-gap.